TAVI has evolved over the last few years from a high-risk procedure to a standard of care for patients suffering from aortic valve stenosis. This rapid evolution has led to expanded patient indications and new challenges to safely and efficiently treat more patients who are younger over time.
In this webinar, the faculty will discuss latest clinical evidence for the novel ACURATE neo2™ Aortic Valve System designed with a number of new features and to understand how improvements in design may help optimize patient outcomes.
The live case from Leipzig, will address the topic of coronary access after TAVI, challenges and solutions to achieve a successful implant that will preserve coronary access for future interventions. Prof Mohamed Abdel-Wahab with Dr Johannes Wilde will provide insights on commissural alignment with the ACURATE Valve Platform.
The discussion will be facilitated by Prof Raj Makkar and Prof Ole De Backer.
This webinar is supported by